Tuesday, June 10, 2025
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home 2019

Yearly Archives: 2019

Biotech News

Is Telemedicine For Real?

Editor / Curator -
Biotech News

Mass General Brigham to Invest $100 Million in Telehealth and Digital...

Editor / Curator -
Biotech Stock Review, Dyve Pharma
Biotech News

Dyve Biosciences (Private) Receives FDA Clearance to Begin Phase 2 Study...

Editor / Curator -
Internet Stock Review
Internet News

New Preferred Stock IPOs, October 2019

Editor / Curator -
biogen, biotech stock review
Biotech News

“I Dare the FDA not to Approve Our Drug.”

Editor / Curator -
Mitesco, Biotech Stock Review
Incubator

True Nature (TNTY), a Medtech Startup Incubator Pays Down Some Toxic...

Editor / Curator -
Biotech News

Frontier Bio (FBIO) Bolstering it’s Warchest.

Editor / Curator -
True Nature, Mitesco, Biotech Stock Review
Incubator

Is True Nature (TNTY) $0.04, Nearing a Breakout?

Editor / Curator -
True Nature, Mitesco, Biotech Stock Review
Accelerator

True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.

Editor / Curator -
AR THreats Report, Biotech Stock Reciew
Superbug News - CoronaVirus Watch List

AR Threats Report (CDC)

Editor / Curator -
123...17Page 2 of 17

Latest article

United States Antimony (UAMY) on Fox News.

Gold Stock Analyst Editor / Curator -
DALLAS, TX / ACCESS Newswire / June 4, 2025 / United States Antimony Corporation ("USAC," "US Antimony," the "Company"), (NYSE American: UAMY), announced today that its Chairman...

Institutional Analyst: Latest Newsletter.

All News Editor / Curator -
Biotechnology, Beverages, Precious Metals, Psychedelics, and Technology. Perpetua Resources (PPTA) Joins the Billion Dollar Club Launching Institutional Gold Analyst and Gold Investor Conference1. Adding Perpetua Resources...

Blue Ocean Equities Report on Antimony.

All News Editor / Curator -
Antimony Macro Note: Don’t expect Sb prices to pull back anytime soon! ANTIMONY MACRO NOTE On Gold Investment Conference A simply fantastic report (best in world) though...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.